Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Hamouda

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|August 18, 2022
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive MacrophagesAleksandar Murgaski, Máté Kiss, Helena Van Damme, et al.
Nature Communications|April 23, 2026
Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-SeqPauline M R Bardet, Lize Allonsius, Eva Hadadi, et al.
Blood|January 29, 2021
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosisMarcelo A S Toledo, Malrun Gatz, Stephanie Sontag, et al.
Nature Communications|December 5, 2024
Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunityAhmed E I Hamouda, Jessica Filtjens, Elisabeth Brabants, et al.
European Journal of Immunology|December 23, 2022
Guidelines for mouse and human DC functional assaysBjörn E Clausen, Lukas Amon, Ronald A Backer, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|August 18, 2022
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive MacrophagesAleksandar Murgaski, Máté Kiss, Helena Van Damme, et al.
Nature Communications|April 23, 2026
Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-SeqPauline M R Bardet, Lize Allonsius, Eva Hadadi, et al.
Blood|January 29, 2021
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosisMarcelo A S Toledo, Malrun Gatz, Stephanie Sontag, et al.
Nature Communications|December 5, 2024
Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunityAhmed E I Hamouda, Jessica Filtjens, Elisabeth Brabants, et al.
European Journal of Immunology|December 23, 2022
Guidelines for mouse and human DC functional assaysBjörn E Clausen, Lukas Amon, Ronald A Backer, et al.
Pageof 5